×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SNY – sanofi - american depositary shares (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SNY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/26
09:13 am
sny
Honoring 45 Organ, Eye and Tissue Donors, Living Donors and Recipients: The 2026 OneLegacy Donate Life Rose Parade® Float Celebrates 23 Years of Participation in the Iconic Rose Parade® [Yahoo! Finance]
Low
Report
Honoring 45 Organ, Eye and Tissue Donors, Living Donors and Recipients: The 2026 OneLegacy Donate Life Rose Parade® Float Celebrates 23 Years of Participation in the Iconic Rose Parade® [Yahoo! Finance]
12/24
07:01 pm
sny
Sanofi to Buy Dynavax to Boost Vaccines Business [Yahoo! Finance]
Low
Report
Sanofi to Buy Dynavax to Boost Vaccines Business [Yahoo! Finance]
12/24
02:17 pm
sny
What Sanofi Is Getting Through The Acquisition Of Dynavax [Seeking Alpha]
Neutral
Report
What Sanofi Is Getting Through The Acquisition Of Dynavax [Seeking Alpha]
12/24
11:21 am
sny
Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise [Yahoo! Finance]
Low
Report
Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise [Yahoo! Finance]
12/24
09:33 am
sny
BP to sell 65% of Castrol stake, Sanofi's $2.2B deal for Dynavax [Yahoo! Finance]
Low
Report
BP to sell 65% of Castrol stake, Sanofi's $2.2B deal for Dynavax [Yahoo! Finance]
12/24
09:29 am
sny
BP to sell 65% of Castrol stake, Sanofi's $2.2B deal for Dynavax [Yahoo! Finance Canada]
Low
Report
BP to sell 65% of Castrol stake, Sanofi's $2.2B deal for Dynavax [Yahoo! Finance Canada]
12/24
08:03 am
sny
Biggest Mover Wednesday: Dynavax Stock Soars on $2.2 billion Acquisition Deal [Yahoo! Finance]
Low
Report
Biggest Mover Wednesday: Dynavax Stock Soars on $2.2 billion Acquisition Deal [Yahoo! Finance]
12/24
07:04 am
sny
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion [CNBC]
Low
Report
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion [CNBC]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
05:35 pm
sny
Form SCHEDULE 13G/A Sanofi Filed by: Amundi
Low
Report
Form SCHEDULE 13G/A Sanofi Filed by: Amundi
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/16
Sanofi, Regeneron begin testing arthritis drug as coronavirus treatment [Reuters (UK)]
8.5%
3/13 Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency Use [Canadian Business Journal (Canada)] 8.2%
12/9 Sanofi ends research in diabetes, narrows units to spur profits [Reuters] 7.0%
3/17 Sanofi SA (NYSE: SNY) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. 6.5%
4/24 Sanofi confirms targets, strong demand for pain killers lifts first quarter [CNBC] 6.1%
6/6 Runners-Up From Our Sixth Annual Student Editorial Contest [The New York Times] 6.0%
3/3 FDA Approves Sanofi's Multiple Myeloma Drug [The Motley Fool] 5.9%
2/28 UPDATE 1-Sanofi to pay $11.9 mln to resolve U.S. drug charity kickback probe [Reuters] 5.4%
2/6 Sanofi delivers strong 2019 business EPS growth of 6.8% at CER 4.2%
4/13 Reasons for hope: the drugs, tests and tactics that may conquer coronavirus [Reuters] 3.6%
3/13 Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency Use [Canadian Business Journal (Canada)] 8.2%
12/9 Sanofi ends research in diabetes, narrows units to spur profits [Reuters] 7.0%
3/17 Sanofi SA (NYSE: SNY) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. 6.5%
4/24 Sanofi confirms targets, strong demand for pain killers lifts first quarter [CNBC] 6.1%
6/6 Runners-Up From Our Sixth Annual Student Editorial Contest [The New York Times] 6.0%
3/3 FDA Approves Sanofi's Multiple Myeloma Drug [The Motley Fool] 5.9%
2/28 UPDATE 1-Sanofi to pay $11.9 mln to resolve U.S. drug charity kickback probe [Reuters] 5.4%
2/6 Sanofi delivers strong 2019 business EPS growth of 6.8% at CER 4.2%
4/13 Reasons for hope: the drugs, tests and tactics that may conquer coronavirus [Reuters] 3.6%
TOP News Decliners
3/17
Here are some of the existing drugs that may be repurposed to treat coronavirus [MSNBC.com]
-7.7%
3/6 Algernon Announces Availability of its NP-120 Ifenprodil Drug for Compassionate Use for Coronavirus [Canadian Business Journal (Canada)] -6.6%
3/16 Regeneron Is A Phenomenal Growth Story; Buying The Current Dip Could Be A Wise Move [Seeking Alpha] -6.5%
4/14 GlaxoSmithKline CEO calls coronavirus vaccine partnership with Sanofi 'unprecedented collaboration' [CNBC] -4.8%
4/29 GlaxoSmithKline plc (GSK) Q1 2020 Earnings Call Transcript [The Motley Fool] -4.5%
10/31 Sanofi Q3 well on track -4.0%
1/30 Human Insulin Is Available For As Little As $24.88 - But It’s Not For Everyone [Forbes] -3.4%
4/6 Sanofi upsizes debt offerings to €4B; shares up 2% [Seeking Alpha] -3.3%
3/2 Sanofi Pasteur researcher warns against overconfidence with coronavirus vaccine development [CNBC] -3.1%
3/5 Form IRANNOTICE Sanofi -3.0%
3/6 Algernon Announces Availability of its NP-120 Ifenprodil Drug for Compassionate Use for Coronavirus [Canadian Business Journal (Canada)] -6.6%
3/16 Regeneron Is A Phenomenal Growth Story; Buying The Current Dip Could Be A Wise Move [Seeking Alpha] -6.5%
4/14 GlaxoSmithKline CEO calls coronavirus vaccine partnership with Sanofi 'unprecedented collaboration' [CNBC] -4.8%
4/29 GlaxoSmithKline plc (GSK) Q1 2020 Earnings Call Transcript [The Motley Fool] -4.5%
10/31 Sanofi Q3 well on track -4.0%
1/30 Human Insulin Is Available For As Little As $24.88 - But It’s Not For Everyone [Forbes] -3.4%
4/6 Sanofi upsizes debt offerings to €4B; shares up 2% [Seeking Alpha] -3.3%
3/2 Sanofi Pasteur researcher warns against overconfidence with coronavirus vaccine development [CNBC] -3.1%
3/5 Form IRANNOTICE Sanofi -3.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: